SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

LOPEZ GEORGE A

(Last)

(First)

(Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE

92673

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, Pres., CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2003

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/05/2003		P		1,000	A	$23.85	1,000	D
Common Stock	08/05/2003		P		100	A	$23.79	100	D
Common Stock	08/05/2003		P		900	A	$23.99	900	D
Common Stock	08/05/2003		P		1,000	A	$23.71	1,000	D
Common Stock	08/05/2003		P		81	A	$23.74	81	D
Common Stock	08/05/2003		P		919	A	$23.93	5,000	D
Common Stock owned by George A. Lopez, MD 2nd Fam. Ltd. Ptsh								1,186,843⁽¹⁾	I	See Note⁽²⁾
Common Stock owned by Lopez Family Trust								23,223	I	See Note⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options to Acquire Common Stock	$5.54							01/30/1999	01/31/2008	Common Stock	300,000		300,000	D
Options to Acquire Common Stock	$10.25							01/30/1999	06/26/2007	Common Stock	352,763		352,763	D
Options to Acquire Common Stock	$8.17							12/31/2001	01/02/2009	Common Stock	101,017		101,017	D
Options to Acquire Common Stock	$8.17							01/30/1999	01/02/2009	Common Stock	48,982		48,982	D
Options to Acquire Common Stock	$8.17							11/25/2001	01/02/2009	Common Stock	975,000		975,000	D
Options to Acquire Common Stock	$10.67							12/31/2001	09/02/2010	Common Stock	16,512		16,512	D
Options to Acquire Common Stock	$10.33							12/31/2001	12/20/2010	Common Stock	133,488		133,488	D
Options to Acquire Common Stock (Granted 9/9/00)	$14.63							08/08/1988⁽⁴⁾⁽⁵⁾	09/09/2011	Common Stock	300,000		300,000	D
Options to Acquire Common Stock (Granted 12/9/00)	$18.63							08/08/1988⁽⁴⁾⁽⁵⁾	12/09/2011	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 3/9/2001)	$19.46							08/08/1988⁽⁴⁾⁽⁵⁾	03/09/2012	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 6/8/01)	$25.62							08/08/1988⁽⁴⁾⁽⁵⁾	06/08/2012	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 9/9/01)	$23.77							08/08/1988⁽⁴⁾⁽⁵⁾	09/09/2012	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 12/9/01)	$28.62							08/08/1988⁽⁴⁾⁽⁵⁾	12/09/2012	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 3/8/02)	$33.55							08/08/1988⁽⁴⁾⁽⁵⁾	03/08/2013	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 6/9/02)	$30.18							08/08/1988⁽⁴⁾⁽⁵⁾	06/09/2013	Common Stock	75,000		75,000	D
Options to Acquire Common Stock (Granted 9/9/02)	$36.03							08/08/1988⁽⁴⁾⁽⁵⁾	09/09/2013	Common Stock	50,000		50,000	D
Options to Acquire Common Stock (Granted 12/9/02)	$36.87							08/08/1988⁽⁴⁾⁽⁵⁾	12/09/2013	Common Stock	50,000		50,000	D
Options to Acquire Common Stock (Granted 3/9/03)	$26.15							08/08/1988⁽⁴⁾⁽⁵⁾	03/09/2014	Common Stock	50,000		50,000	D
Options to Acquire Common Stock (Granted 6/9/03)	$32.68							08/08/1988⁽⁴⁾⁽⁵⁾	06/09/2014	Common Stock	50,000		50,000	D

Explanation of Responses:

1. Excludes 22,959 shares held by Diana K. Lopez, M.D. Dr. Lopez disclaims any beneficial interest in the shares held by his wife.

2. Dr. Lopez holds a one percent general partnership interest in the Partnership. As general partner, he has power to vote and power to dispose of the 1,186,843 shares owned by the Partnership and may be deemed to be beneficial owners of such shares. The Partnership acquired the shares on 2/24/99 from Trusts for the benefit of the Lopez' children, the Christopher George Lopez Children's Trust and the Nicholas George Lopez Children's Trust, which own a 99% limited partnership interest in the Partnership. The Drs. Lopez are not trustees of and have no interest in their children's Trusts. Except to the extent of their undivided one percent general partnership interest in the assets of the Partnership, the Drs. Lopez disclaim any beneficial ownership of the shares owned by the Partnership.

3. Drs. Lopez are trustees and beneficiaries of the Family Trust. Except to the extent of their pecuniary interests as beneficiaries of the Family Trust, Drs. Lopez disclaim any beneficial ownership of the shares owned by the Family Trust.

4. Not a new transaction. Filed for the sole purpose of supplying the date as provided by the SEC. In fact, no date applies.

5. Options exercisable one-third annually over the first three anniversaries of the grant date.

Remarks:

	George A. Lopez, M.D.	08/05/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.